药物性肝损伤不良反应分析
投稿时间:2024-04-09  修订日期:2024-10-29  点此下载全文
引用本文:
摘要点击次数: 117
全文下载次数: 0
作者单位邮编
张岩 中国人民解放军北部战区总医院 110016
王智慧 沈阳药科大学 110016
李炎君 中国人民解放军北部战区总医院药剂科 110016
刘家荟 中国人民解放军北部战区总医院药剂科 110016
邓娇 中国人民解放军北部战区总医院药剂科 110016
原苑 中国人民解放军北部战区总医院药剂科 110016
任天舒 中国人民解放军北部战区总医院药剂科 110016
张敬一 中国人民解放军北部战区总医院药剂科 110016
中文摘要:目的 对某医院近十年的药物性肝损伤不良反应报告进行分析,探讨药物性肝损伤的特点及相关规律,为临床安全用药提供借鉴。方法 对我院2011年至2021年间上报至医院不良反应监测系统的259例药物所致肝损伤进行帕累托分析。结果259例ADR报告中,药物性肝损伤最常见类型为肝细胞损伤型(37.84%),引发药物性肝损伤的年龄段主要在46岁以上,共195例(75.28%)。药物种类主要有心血管疾病用药(44.02%)、抗感染药(23.94%)及抗肿瘤药(11.58%)。其中心血管药物中阿托伐他汀钙40mg及以上占比最高,共53例(46.49%);抗感染药物中主要为头孢菌素类(31.58%)、碳青霉烯类(17.54%)、抗真菌类(19.30%)、喹诺酮类(11.29%)。不良反应发生时间主要在用药6天及以内内(69.88%),不良反应持续时间多为1-2周(31.66%)。多数患者好转(47.88%)或治愈(37.07%)。结论 对于中老年患者,应用心血管系统药物、抗感染药物或抗肿瘤药物时,需要至少在6天及以内监测患者肝功能变化,如有异常应及时停药或给予治疗,从而避免药物性肝损伤的进展。
中文关键词:药物性肝损伤  药物不良反应  帕累托分析  用药安全性
 
Adverse reaction analysis of drug-induced liver injury
Abstract:Objective To analyze the adverse reaction reports of drug-induced liver injury in recent ten years, explore the characteristics and related rules of drug-induced liver injury, and provide reference for clinical safe drug use. Methods We collected ADRs in our hospital from 2011 to 2021 which belongde to drug-induced liver injuries, and carried on Pareto analysis . Results In 259 ADR reports, The most common type of drug-derived liver injury was hepatocellular injury (37.84%). The age of drug-induced liver injury was mainly over 46 years, totaling 195 (75.28%). Drugs were mainly distributed in cardiovascular system medicine (44.02%), anti-infective medicine (23.94%) and anti-tumor medicine (11.58%). Among the cardiovascular drugs, atorvastatin calcium 40mg and over were the highest proportion, with 53 cases (46.49%). The main anti-infectious drugs were cephalosporins (29.0%), carbapenem (19.4%), antifungal (17.7%) and quinolones (11.29%). Adverse reactions occurred within 7 days (69.88%), the duration of adverse reactions was 1-2 weeks (31.66%), and most patients improved (47.88%) or cured (37.07%). Conclusion For middle-aged and elderly patients, when the application of cardiovascular system drugs, anti-infective drugs or anti-tumor drugs, it is necessary to monitor the liver function changes of patients for at least 7 days . If there are abnormalities, the drugs should be stopped or given treatment in time, so as to avoid the progress of drug-induced liver injury.
keywords:Drug-induced liver injury  adverse drug reactions  Pareto analysis  medication safety
  查看/发表评论  下载PDF阅读器
关闭

分享按钮